Literature DB >> 24353050

A review of the use of ketamine in pain management.

Qutaiba A Tawfic1.   

Abstract

Ketamine is a noncompetitive antagonist of N-methyl-d-aspartate receptor. It has been widely used in anesthesia and pain management. Ketamine has been administered via the intravenous, intramuscular, subcutaneous, oral, rectal, topical, intranasal, sublingual, epidural, and caudal routes. Ketamine improves postoperative and posttrauma pain scores and reduces opioid consumption. It has special indication for patients with opioid tolerance, acute hyperalgesia, and neuropathic pain. It also has a role in the management of chronic pain including both cancer and noncancer pain. Recreational use of ketamine is increasing as well through different routes of administration like inhalation, smoking, or intravenous injection. Long-time exposure to ketamine, especially in the abusers, may lead to serious side effects. This review is trying to define the role of ketamine in pain management.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24353050     DOI: 10.5055/jom.2013.0180

Source DB:  PubMed          Journal:  J Opioid Manag        ISSN: 1551-7489


  14 in total

Review 1.  Prevention of chronic post-surgical pain: the importance of early identification of risk factors.

Authors:  Qutaiba Tawfic; Kamal Kumar; Zameer Pirani; Kevin Armstrong
Journal:  J Anesth       Date:  2017-03-27       Impact factor: 2.078

Review 2.  Expanding Role of NMDA Receptor Antagonists in the Management of Pain.

Authors:  Denise Kreutzwiser; Qutaiba A Tawfic
Journal:  CNS Drugs       Date:  2019-04       Impact factor: 5.749

3.  Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease.

Authors:  Raissa Nobrega; Kathy A Sheehy; Caroline Lippold; Amy L Rice; Julia C Finkel; Zenaide M N Quezado
Journal:  Pediatr Res       Date:  2017-09-13       Impact factor: 3.756

Review 4.  Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior.

Authors:  Faryal Mallick; Cheryl B McCullumsmith
Journal:  Curr Psychiatry Rep       Date:  2016-06       Impact factor: 5.285

Review 5.  Opioid-Sparing Effect of Ketamine in Children: A Meta-Analysis and Trial Sequential Analysis of Published Studies.

Authors:  Daphnée Michelet; Julie Hilly; Alia Skhiri; Rachida Abdat; Thierno Diallo; Christopher Brasher; Souhayl Dahmani
Journal:  Paediatr Drugs       Date:  2016-12       Impact factor: 3.022

6.  Pain management in ambulatory surgery-a review.

Authors:  Jan G Jakobsson
Journal:  Pharmaceuticals (Basel)       Date:  2014-07-24

7.  Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study.

Authors:  Kathy A Sheehy; Elena A Muller; Caroline Lippold; Mehdi Nouraie; Julia C Finkel; Zenaide M N Quezado
Journal:  BMC Pediatr       Date:  2015-12-01       Impact factor: 2.125

8.  Clinical significance of interleukin‑6 and inducible nitric oxide synthase in ketamine‑induced cystitis.

Authors:  Chi-Jung Huang; Fa-Kung Lee; Shao-Kuan Chen; Chih-Cheng Chien; Sheng-Tang Wu; Yen-Chieh Wang
Journal:  Int J Mol Med       Date:  2017-11-17       Impact factor: 4.101

9.  Effects of ketamine, s-ketamine, and MK 801 on proliferation, apoptosis, and necrosis in pancreatic cancer cells.

Authors:  Manuela Malsy; Kristina Gebhardt; Michael Gruber; Christoph Wiese; Bernhard Graf; Anika Bundscherer
Journal:  BMC Anesthesiol       Date:  2015-07-29       Impact factor: 2.217

10.  Subanesthetic ketamine for pain management in hospitalized children, adolescents, and young adults: a single-center cohort study.

Authors:  Kathy A Sheehy; Caroline Lippold; Amy L Rice; Raissa Nobrega; Julia C Finkel; Zenaide Mn Quezado
Journal:  J Pain Res       Date:  2017-04-05       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.